A study of 80 patients with PC and 80 healthy controls found a correlation between increased survivin concentration (by ELISA) and poor OS [73], supported by more recent observations of higher serum survivin concentrations before treatment in patients with PC than in healthy controls and their association with worse outcomes [74]. This evidence concerns the gene BIRC5 and pachyonychia congenita.